Skip to main content

COVID-19 Advisory: Visitor restrictions are in place for all Phoenix Children’s locations. Masks are required for all visitors and for patients ages 2+. For more information, visit our COVID-19 Resource Center.

Michael C. Kruer, MD

Edit Profile

Michael C. Kruer, MD

Edit Profile

Specialty

Areas of Expertise

  • Pediatric Movement Disorders Neurogenetics

Locations

Phoenix Children's Medical Group - Neurology (East Bldg)

1919 E Thomas Rd
Phoenix, AZ 85016-7710
United States

Get Driving Directions

Phoenix Children's Medical Group - Neurology (MOB)

3370 S Mercy Rd
Gilbert, AZ 85297-0417
United States

Get Driving Directions

+Education & Training

Board Certification

Neurodevelopmental Disabilities; Pediatrics; Neurology with Special Qualification in Child Neurology

Medical School / Education

University of Arizona

Residency

Pediatrics, Phoenix Children's Hospital - Phoenix, AZ

Fellowship

(Neurodevelopmental Disabilities, Molecular Neurogenetics) Oregon Health & Science University

Internship

Phoenix Children's Hospital - Phoenix, AZ

+Academic and Professional Affiliations

Academic Affiliations

Department of Child Health, University of Arizona College of Medicine PhoenixProgram in Neuroscience, Arizona State University

Professional Affiliations

Child Neurology Society, American Society of Human Genetics, Movement Disorders Society, American Academy of Cerebral Palsy & Developmental Medicine, American Academy of Neurology, Society for Neuroscience

+Awards

  • CH Heart & Hand Award for Clinical Excellence 2021 - Researcher of the Year
  • * Doris Duke Charitable Foundation Clinical Scientist Development Award (2014)* Shields Award, Child Neurology Foundation (2011)* Doernbecher Children's Hospital Award for Pediatric Research (2010) * American Academy of Neurology Clinical Research Training Award (2009)

+Research & Publications

Aravamuthan BR, Fehlings D, Shetty S, Fahey M, Gilbert L, Tilton A, Kruer MC. Variability in Cerebral Palsy Diagnosis. Pediatrics. 2021 Feb;147(2):e2020010066. doi: 10.1542/peds.2020-010066. Epub 2021 Jan 5. PMID: 33402528; PMCID: PMC7906070.

Jin SC, Lewis SA, Bakhtiari S, Zeng X, Sierant MC, Shetty S, Nordlie SM, Elie A, Corbett MA, Norton BY, van Eyk CL, Haider S, Guida BS, Magee H, Liu J, Pastore S, Vincent JB, Brunstrom-Hernandez J, Papavasileiou A, Fahey MC, Berry JG, Harper K, Zhou C, Zhang J, Li B, Zhao H, Heim J, Webber DL, Frank MSB, Xia L, Xu Y, Zhu D, Zhang B, Sheth AH, Knight JR, Castaldi C, Tikhonova IR, Lopez-Giraldez F, Keren B, Whalen S, Buratti J, Doummar D, Cho M, Retterer K, Millan F, Wang Y, Waugh JL, Rodan L, Cohen JS, Fatemi A, Lin AE, Phillips JP, Feyma T, MacLennan SC, Vaughan S, Crompton KE, Reid SM, Reddihough DS, Shang Q, Gao C, Novak I, Badawi N, Wilson YA, McIntyre SJ, Mane SM, Wang X, Amor DJ, Zarnescu DC, Lu Q, Xing Q, Zhu C, Bilguvar K, Padilla-Lopez S, Lifton RP, Gecz J, MacLennan AH, Kruer MC. Mutations disrupting neuritogenesis genes confer risk for cerebral palsy. Nat Genet. 2020 Oct;52(10):1046-1056. doi: 10.1038/s41588-020-0695-1. Epub 2020 Sep 28.

Richard EM, Bakhtiari S, Marsh APL, Kaiyrzhanov R, Wagner M, Shetty S, Pagnozzi A, Nordlie SM, Guida BS, Cornejo P, Magee H, Liu J, Norton BY, Webster RI, Worgan L, Hakonarson H, Li J, Guo Y, Jain M, Blesson A, Rodan LH, Abbott MA, Comi A, Cohen JS, Alhaddad B, Meitinger T, Lenz D, Ziegler A, Kotzaeridou U, Brunet T, Chassevent A, Smith-Hicks C, Ekstein J, Weiden T, Hahn A, Zharkinbekova N, Turnpenny P, Tucci A, Yelton M, Horvath R, Gungor S, Hiz S, Oktay Y, Lochmuller H, Zollino M, Morleo M, Marangi G, Nigro V, Torella A, Pinelli M, Amenta S, Husain RA, Grossmann B, Rapp M, Steen C, Marquardt I, Grimmel M, Grasshoff U, Korenke GC, Owczarek-Lipska M, Neidhardt J, Radio FC, Mancini C, Claps Sepulveda DJ, McWalter K, Begtrup A, Crunk A, Guillen Sacoto MJ, Person R, Schnur RE, Mancardi MM, Kreuder F, Striano P, Zara F, Chung WK, Marks WA, van Eyk CL, Webber DL, Corbett MA, Harper K, Berry JG, MacLennan AH, Gecz J, Tartaglia M, Salpietro V, Christodoulou J, Kaslin J, Padilla-Lopez S, Bilguvar K, Munchau A, Ahmed ZM, Hufnagel RB, Fahey MC, Maroofian R, Houlden H, Sticht H, Mane SM, Rad A, Vona B, Jin SC, Haack TB, Makowski C, Hirsch Y, Riazuddin S, Kruer MC. Bi-allelic variants in SPATA5L1 lead to intellectual disability, spastic-dystonic cerebral palsy, epilepsy, and hearing loss. Am J Hum Genet. 2021 Oct 7;108(10):2006-2016. doi: 10.1016/j.ajhg.2021.08.003. PMID: 34626583; PMCID: PMC8546233.

My lab is focused on the molecular basis of movement disorders (www.kruerlab.org)Our largest project is an international collaborative study of the genetic basis of cerebral palsy (www.facebook/cpgrn)
Share this page